Mechanical Valve Thrombosis on Rivaroxaban: Are Novel Anticoagulants Really an Option?
Publication/Presentation Date
1-1-2017
Abstract
This is a case of a 54-year-old female with a history of mechanical aortic valve replacement who presented in cardiogenic shock. Her primary care provider started her on rivaroxaban for anticoagulation therapy. An urgent transesophageal echocardiogram revealed a significant gradient and thrombosis on one leaflet of the valve that was immobile. Given that she was not a surgical candidate, she underwent thrombolysis. However, she later died due to complications from the thrombotic valve. The utility of target-specific oral anticoagulants has yet to be established in clinical practice.
Volume
13
Issue
2
First Page
73
Last Page
75
ISSN
1947-6108
Published In/Presented At
Kumar, V., Kelly, S., Raizada, A., Yee, J., Anuwatworn, A., Stys, A., & Stys, M. (2017). Mechanical Valve Thrombosis on Rivaroxaban: Are Novel Anticoagulants Really an Option?. Methodist DeBakey cardiovascular journal, 13(2), 73–75. https://doi.org/10.14797/mdcj-13-2-73
Disciplines
Medicine and Health Sciences
PubMedID
28740586
Department(s)
Department of Medicine, Cardiology Division
Document Type
Article